Labroots

New Drug Reduces Seizures by up to 91% in Severe Epilepsy

An experimental drug reduced seizures by up to 91% in children with Dravet syndrome. | Drug Discovery And Development ...
European Medical Journal

Early Trials Highlight Zorevunersen Potential in Dravet Syndrome

Early studies show zorevunersen may reduce seizures and improve outcomes in Dravet syndrome. Learn more about the studies.
The American Journal of Managed Care

Researchers Find Genetic Variant Linked With Earlier-Onset Childhood Epilepsy

A specific genetic variant of SCN1A may be associated with earlier-onset epilepsy. SCN1A variants are most commonly associated with Dravet syndrome, the most common genetic epilepsy, which is ...
Morningstar

Encoded Therapeutics Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by U.S. FDA for ETX101 in SCN1A+ Dravet Syndrome

Designation based on preliminary clinical evidence indicating the potential for ETX101 to address unmet medical needs associated with SCN1A+ Dravet syndrome Completion of enrollment in POLARIS ...
Business Wire

Encoded Therapeutics to Present Initial ENVISION Natural History Study Data of Children With SCN1A+ Dravet Syndrome at the American Epilepsy Society 2021 Annual Meeting

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Encoded Therapeutics today announced the upcoming presentation of initial data from the ENVISION prospective natural history study of children with SCN1A+ ...